Background: Chemokines produced by adipose tissue (AT) are involved in the devel-
tis. 13 It has been reported that mice lacking CCL19 show protection from diet induced obesity and insulin resistance. 14 However, the human adipose tissue expression of CCL19 and its relationship with other inflammatory and metabolic markers in obesity remains unclear.
Herein, we report elevated CCL19 gene expression in the adipose tissue samples from obese individuals and its association with inflammatory and insulin resistance markers.
| MATERIAL AND METHODS

| Study population and anthropometric measurements
A total of 56 non-diabetic (26 obese, 21 overweight, and 9 lean) individuals were recruited in this study. The participants were classified as lean, overweight, and obese based on their body mass index (BMI). All participants gave written informed consent, and the study was approved by ethics committee of Dasman Diabetes Institute, Kuwait.
Height and weight were measured using calibrated portable electronic weighing scales and portable inflexible height measuring bars; the waist circumference was measured using constant tension tape. The whole-body composition including percent body fat, soft lean mass, and total body water was measured using IOI353 Body Composition
Analyser (Jawon Medical, South Korea). BMI was calculated using standard formula: BMI = body weight (kg) / height (m 2 ). The characteristics of the participants are summarized in Table 1 .
| Collection of subcutaneous adipose tissue
Human adipose tissue samples (~0.5 g) were collected via abdominal subcutaneous fat pad biopsy lateral to the umbilicus using standard surgical method. Briefly, the periumbilical area was sterilized by alcohol swabbing and then locally anaesthetised using 2% lidocaine (2 mL). Through a small superficial skin incision (0.5 cm), fat tissue was collected. 15 After removal, the biopsy tissue was further incised into smaller pieces, rinsed in cold phosphate buffered saline, fixed in glucose and insulin concentrations using the following formula:
Plasma high sensitivity CRP (CRP) levels were measured by ELISA (Biovendor, USA), and plasma adiponectin was measured using immunobead assays (Luminex, Austin, TX, USA). All assays were performed following instructions of the manufacturers. to control (lean adipose tissue) was calculated using 2−ΔΔCt method, and the relative mRNA expression was expressed as fold expression over the average control gene expression. 17 
| Statistical analysis
| Increased CCL19 gene expression in the adipose tissue relates to inflammatory signatures
The role of adipose tissue CCL19 expression in metabolic inflammation remains unclear. Next, we wanted to know whether the elevated CCL19 mRNA expression in obese adipose tissue was concordant with the inflammatory markers in this compartment. In this regard, as shown in Table 2 
| DISCUSSION
In obesity, pro-inflammatory chemokines/cytokines are considered to trigger systemic and local inflammatory changes leading to insulin resistance, T2D, and related complications. [18] [19] [20] [21] [22] The chemokine CCL19 has been associated with a number of inflammatory conditions including multiple sclerosis 23 , atherosclerosis, 24 and rheumatoid arthritis . 25 In the present study, we show that CCL19 gene expression was Correlations between the biomarkers were examined using the Pearson correlation coefficient.
*Significant (P < 0.01).
**Very significant (P < 0.001).
***Highly significant (P < 0.0001). CXCL, (C-X-C motif) ligand; IL, interleukin; TGF-β, transforming growth factor beta; TNF-α, tumour necrosis factor alpha; IP-10, interferongamma-induced protein.
Correlations between the biomarkers were examined using the Pearson correlation coefficient. *Significant (P < 0.05).
**Highly significant (P < 0.01).
